• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锶 - 89姑息性放疗用于广泛骨转移形成的情况(作者译)

[Palliative radiotherapy with Strontium-89 in case of extended formation of skeleton metastases (author's transl)].

作者信息

Kutzner J, Grimm W, Hahn K

出版信息

Strahlentherapie. 1978 May;154(5):317-22.

PMID:77576
Abstract

In order to allay pains or make them cease, fifteen patients with extended tumors and generalized formation of skeleton metastases were submitted in 1976 to an internal palliative radiotherapy. They received between 0.8 and 2.7 mCi of Sr-89, five patients were treated again after four to five months because the pains had reappeared. The results were relatively good. Two patients showed a prompt effect and were completely free of pains within 48 hours, three patients did not present any demonstrable effect. The analgetic effect remained from four days to four months. Due to the utilization of the pure beta emitter Sr-89, the radiation doses measured in the patients after the application are relatively small: after the application they amount at most to 0.5 mR/h in a distance of 1 m.

摘要

为了减轻疼痛或使其停止,1976年对15例患有广泛性肿瘤并伴有全身骨骼转移瘤形成的患者进行了内照射姑息性放疗。他们接受了0.8至2.7毫居里的锶-89,有5例患者在四到五个月后因疼痛再次出现而接受了再次治疗。结果相对较好。2例患者迅速起效,在48小时内完全无痛,3例患者未显示出任何明显效果。止痛效果持续了四天至四个月。由于使用了纯β发射体锶-89,应用后在患者身上测得的辐射剂量相对较小:应用后在1米距离处最多为0.5毫伦琴/小时。

相似文献

1
[Palliative radiotherapy with Strontium-89 in case of extended formation of skeleton metastases (author's transl)].锶 - 89姑息性放疗用于广泛骨转移形成的情况(作者译)
Strahlentherapie. 1978 May;154(5):317-22.
2
[Internal radiotherapy using strontium-89 in metastases-induced pain].
MMW Munch Med Wochenschr. 1977 Sep 30;119(39):1251-2.
3
[Treatment of pains from bone metastases with 90Y (author's transl)].
Nuklearmedizin. 1981 Oct;20(5):229-35.
4
[Management of bone metastases. Indication for radiotherapy and surgical internal fixation (author's transl)].骨转移瘤的治疗。放射治疗及手术内固定的适应证(作者译)
Radiologe. 1978 Aug;18(8):310-5.
5
Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).使用锶-89(美他生)缓解转移性癌症患者的骨痛
Cancer Nurs. 1995 Aug;18(4):286-91.
6
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].[IV期非小细胞肺癌患者放疗后的生存状况——附287例报告]
Ai Zheng. 2006 Nov;25(11):1419-22.
7
[Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].[放射性物质(32P和89Sr)治疗骨转移疼痛]
Z Urol Nephrol. 1981 Nov;74(11):801-6.
8
[The results of palliative radiotherapy in 50 unselected cases of bone metastases].[50例未经挑选的骨转移患者的姑息性放疗结果]
Wien Klin Wochenschr. 1977 Jan 7;89(1):14-5.
9
Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.氯化锶-89治疗转移性前列腺癌后骨吸收生化标志物的定量分析。
J Nucl Med. 1997 Aug;38(8):1175-9.
10
[Percutaneous radiation therapy for localized and generalized stages of prostatic cancer (author's transl)].前列腺癌局部和全身分期的经皮放射治疗(作者译)
Strahlentherapie. 1981 Mar;157(3):153-6.

引用本文的文献

1
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.第三个千年之交癌症药物治疗的进展
Front Pharmacol. 2018 Nov 13;9:1300. doi: 10.3389/fphar.2018.01300. eCollection 2018.
2
(177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment.(177)用于癌症治疗中靶向骨转移的镥标记大环双膦酸盐。
EJNMMI Res. 2016 Dec;6(1):5. doi: 10.1186/s13550-016-0161-3. Epub 2016 Jan 16.